Key financials
 
Key financials

Selected Key Figures*

The fiscal year of HELLA ends on May 31.

* Please observe the remarks on the Yearly Figures.

02/05/2016
Sales
Adjusted EBIT
Earning for the period
Net financial dept / Net financial liquidity
Equity

Yearly figures

Key figure in € million 2020/2021 2019/2020 2018/2019
Sales [currency- and portfolio adjusted] 6,380 [6.505] 5,829 [5,739] 6,990 [6,770]
Change compared to previous period 9% [13%] -17% [-16%] -1% [5%]
EBIT [adjusted] 454 [510] -343 [227] 808 [572]
Change compared to previous period 232% [125%] -142% [-60%] 41% [5%]
EBITDA [adjusted] 894 [917] 576 [661] 1,191 [948]
Change compared to previous period  55% [39%] 52% [-30%] 17% [-4%]
Earnings for the period 360 -432 630
Change compared to previous period  183% -168% 62%
Earnings per share (in €) 3.22 -3.88 5.67
Change compared to previous period  183% -168% 62%
R&D expenses 603 620 611
Change compared to previous period -3% 2% 7%
Free Cashflow from operating activities [adjusted] 74 [217] 205 [222] 253 [243]
Change compared to previous period -64% [-2%] -19% [-9%] 16% [9%]
Capital expediture 630 431 551
Change compared to previous period 46% -22% 28%
       
EBIT margin [adjusted] 7.1% [8.0%] -5.9% [4.0%] 11.6% [8.4%]
EBITDA margin [adjusted] 14.0% [14.4%] 9.9% [11.5%] 17.0% [14.0%]
R&D expenses in relation to sales 9.5% 10.8% 9.0%
Capital expediture in relation to sales 9.9% 7.5% 7.9%
       
  May 31, 2021 May 31, 2020 May 31, 2019
Net financial liquidity / debt 103 -140 66
Equity ratio 40.6% 37.0% 46.3%
Return on equity (last 12 months) 13.7% -20.5% 25.4%
Number of employees
(headcount; not in € million)
36.500 36,311 38,845
08/19/2021
 
 

Quarterly figures


For further information, please refer to the nine-month financial statement for the fiscal year 2021/2022.

Key Figures
in € million
3rd quarter
FY 2021/2022
3rd quarter
FY 2020/2021
Change to
prior year
Sales [currency and
portfolio-adjusted]
1,616 [1,583] 1,545 [1,545] 4.6% [2.4%]
EBIT [adjusted] 76 [82] 219 [104] -65.3% [-21.0%]
EBITDA [adjuste0d] 181 [188] 317 [203] -42.9% [-7.5%]
Earnings for the period 50 170 -70.6%
Earnings per share (in €) 0.44 1.52 -71.1%
Free cashflow from operating activities [adjusted] -43 [-25] 102 [113] --
R&D expenses 169 149 14.0%
Capital expenditure 114 110 3.8%
       
EBIT margin [adjusted] 4.7% [5.1%] 14.1% [6.7%] -9.5pp [-1.7pp]
EBITDA margin [adjusted] 11.2% [11.6%] 20.5% [13.1%] -9.3pp [-1.5pp]
R&D expenses in relation to sales 10.5% 9.6% +0.9pp
Capital expenditure in relation to sales 7.1% 7.2% -0.1pp
04/07/2022
 
 

Nine-Month-Figures

Key Figures
in € million
Nine Months
FY 2021/2022
Nine Months
FY 2020/2021
Change to
prior year
Sales [currency and
portfolio- adjusted]
4,653 [4,602] 4,646 [4,646] 0.2% [ -0.9%]
EBIT [adjusted] 225 [238] 312 [373] -28.0% [ -36.2%]
EBITDA [adjusted] 529 [541] 594 [655] -10.9% [ -17.3%]
Earnings for the period 154 236 -35.0%
Earnings per share (in €) 1.37 2.12 -35.5%
Free Cashflow from operating activities [adjusted] -269 [-228] 69 [97] --
R&D expenses 507 445 13.9%
Capital expenditure 401 371 8.0%
       
EBIT margin [adjusted] 4.8% [5.1%] 6.7% [8.0%] -1.9pp [-2.9pp]
EBITDA margin [adjusted] 11.4% [11.6%] 12.8% [14.1%] -1.4pp [-2.5pp]
R&D expenses in relation to sales 10.9% 9.6% +1.3pp
Capital expenditure
in relation to sales
8.6% 8.0% +0.6pp
       
  28 Feb 22 31 May 21  
Net financial debt /net financial liquidity (in € million) -352 103 --
Equity ratio 42.2% 40.6% +1.6pp
Return on equity 
(last 12 months)
10.6% 14.6% -4.1p
Number of employees (headcount) 36,092 36,500 -1.1%
04/07/2022
 
 

Sales by business segments

Sales by business segments

As of May 31, 2021

 
 

Regional market coverage

Regional market coverage

As of May 31, 2021

 
 

Employees by regions

Employees by regions

As of May 31, 2021

 
 
 
 
  • icon_druck
 
 
 
Financial calendar
2022-07-20Prelim. Results FY 2021/22
05/25/2022
2022-08-18Annual Results 2021/22
09/14/2021
2022-09-29Results First Quarter FY 2022
05/25/2022
2022-09-30Annual General Meeting Fiscal Year 2021/22
09/14/2021
 
07/28/2016
Contact

Dr. Kerstin Dodel
Investor Relations
Email: investor.ndss@pyefrelations@hella.com

 
03/18/2022
Stock chart
 
09/02/2021